Eugene

[email protected]

LATEST

Bayer To Acquire Cell-Therapy Company BlueRock Therapeutics in $600-Million Deal
By

By
Bayer has agreed to acquire BlueRock Therapeutics, a developer of cell therapies in neurology, cardiology and immunology, in a deal worth up to $600 million. BlueRock develops engineered cell therapies…

Cambrex Agrees to Be Acquired for $2.4 Billion by Private Equity Firm Permira Funds
By

By
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients and drug products, has signed a definitive agreement to be acquired by an affiliate of the Permira Funds, a private equity…

Vertex Announces Succession Plan for New CEO
By

By
Vertex Pharmaceuticals has announced that its Board of Directors has approved the planned transition of Reshma Kewalramani, MD, its current Chief Medical Officer, to become President and Chief Executive Officer…

Takeda, Sosei Heptares Form $1.2-Billion R&D Partnership
By

By
Sosei Heptares, a Tokyo-headquartered pharmaceutical company, has entered into a strategic multi-target partnership with Takeda Pharmaceutical to discover, develop and commercialize small molecules and biologics that modulate G protein-coupled receptor…

Roche Extends Tender Offer Period in Pending $4.3-Billion Acquisition of Spark Therapeutics
By

By
Roche has extended its tender offer period relating to its pending $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from July 31, 2019 to September 3, 2019. Roche extended…

Pfizer, GSK Complete Closing of OTC Joint Venture
By

By
Pfizer has completed the closing of its joint venture with GlaxoSmithKline (GSK) that combines the companies’ respective consumer healthcare businesses. Pfizer owns a 32% equity stake in the joint venture…

Novartis Gains OK to Buy Back Its Former Canadian Sterile Manufacturing Plant
By

By
Novartis has announced that the Superior Court of Quebec has granted Sandoz Canada the right to buy back its former sterile-manufacturing facility in Boucherville, Quebec, Canada. The site has been…

US HHS Announces New Action Plan for Drug Importation
By

By
The US Department of Health and Human Services (HHS) has announced that it and the US Food and Drug Administration (FDA) are publishing a Safe Importation Action Plan that outlines…

Fujifilm Acquires Biogen’s Danish Biologics Mfg Site for Nearly $1 Billion
By

By
Fujifilm has completed its acquisition of Biogen’s large-scale biologics manufacturing site in Hillerød, Denmark, near Copenhagen, for approximately $890 million. With the closing of this transaction, the Hillerød manufacturing site…

European Commission OKs BMS’ $74-Billion Acquisition of Celgene
By

By
Bristol-Myers Squibb (BMS) has announced that the European Commission has granted unconditional approval of BMS’ pending $74-billion acquisition of Celgene The companies had announced the deal in January 2019. The…